Parallax Volatility Advisers, L.P. Apellis Pharmaceuticals, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $64.2 Billion
- Q3 2025
A detailed history of Parallax Volatility Advisers, L.P. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 124,000 shares of APLS stock, worth $2.52 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124,000
Previous 30,000
313.33%
Holding current value
$2.52 Million
Previous $519,000
440.66%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding APLS
# of Institutions
328Shares Held
124MCall Options Held
4.12MPut Options Held
756K-
Avoro Capital Advisors LLC New York, NY12.2MShares$248 Million3.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.99MShares$203 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.64MShares$196 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.29MShares$189 Million0.04% of portfolio
-
Deep Track Capital, LP Greenwich, CT8MShares$163 Million5.71% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.23B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...